Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 383
Selected: 0
NCT IDTitle
NCT05823740Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
NCT01605344Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
NCT01578967Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma
NCT00283244Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
NCT04670068Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
NCT00998101Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy
NCT00767468Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
NCT00448201Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
NCT03544268Academic-Industrial Partnership for Translation of Acoustic Angiography
NCT06296368DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
NCT03717844Registry for Adults With Plasma Cell Disorders (PCD's)
NCT03156244Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients
NCT01702844Single Arm on the Tolerability of Weekly Nab-paclitaxel
NCT06347068Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
NCT06702592Virtual Testis Cancer Lay Support and Survivorship Aim 2
NCT05472792Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
NCT03418792Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
NCT04280640Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes
NCT05887401Physical Activity and Healthy Eating Among Young Adult Cancer Survivors
NCT02768701Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
NCT04645667Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
NCT02768792High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
NCT00003392High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
NCT00577694Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT05612880Physical Function During ARSI Treatment
NCT06860880Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
NCT06896162PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
NCT03488862Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
NCT06674889Rehabilitation Outcomes Study
NCT00486304Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy
NCT01992068Pilot Study: Utilizing Manometry to Assess Radiation-Induced Changes in Esophageal Function
NCT03721068Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
NCT02767362A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
NCT01685762Metformin for the Treatment of Endometrial Hyperplasia
NCT05061095Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
NCT01492881Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
NCT06483555Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
NCT01759355Hybrid PET/MR in the Therapy of Cervical Cancer
NCT01849614Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart
NCT04836455Impact of Vaping Prevention Advertisements
NCT05344950Connecting Audio and Radio Sensing Systems to Improve Care at Home
NCT01773850Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions
NCT04978350Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study
NCT00266110Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
NCT02660710Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma
NCT04083495CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
NCT02281955De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
NCT0548302318-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
NCT00280150Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT04406714Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)